Ezose Sciences, Inc. Forms Alliance With Fast Forward, LLC to Discover Biomarkers to Diagnose Multiple Sclerosis

Published: Oct 24, 2012

PINE BROOK, N.J.--(BUSINESS WIRE)--Ezose Sciences Inc. today announced an alliance with Fast Forward, LLC, a subsidiary of the National Multiple Sclerosis Society, to use Ezose’s GlycanMap® technology in the discovery of biomarkers to help diagnose multiple sclerosis (MS) and improve disease management.

Back to news